Pharming Group NV Net Asset Quality Index
Pharming Group NV net asset quality index. Pharming Group NV (PHAR) has a Net Asset Quality Index of 55.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $489.37 Million minus total liabilities of $220.41 Million yields net assets of $268.96 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Pharming Group NV book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Pharming Group NV (2005–2025)
Net asset quality index of Pharming Group NV from 2005 to 2025. This chart shows how Pharming Group NV's Net Asset Quality Index has evolved across 21 annual periods from 2005 to 2025. As of March 2026, the index stands at 55.0%, representing net assets of $268.96 Million against total assets of $489.37 Million USD. Check PHAR strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Pharming Group NV Net Asset Quality Index by Year (2005–2025)
Pharming Group NV net asset quality index by year from 2005 to 2025. The table below presents the year-by-year Net Asset Quality Index for Pharming Group NV from 2005 to 2025, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Pharming Group NV market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 55.4% | $277.02 Million | $499.81 Million | $222.79 Million | ▲ +0.2 pp |
| 2024 | 55.3% | $221.06 Million | $399.99 Million | $178.92 Million | ▲ +8.0 pp |
| 2023 | 47.3% | $218.78 Million | $462.85 Million | $244.07 Million | ▼ -0.8 pp |
| 2022 | 48.1% | $204.64 Million | $425.80 Million | $221.16 Million | ▼ -0.5 pp |
| 2021 | 48.6% | $192.92 Million | $397.31 Million | $204.40 Million | ▲ +4.7 pp |
| 2020 | 43.8% | $150.16 Million | $342.55 Million | $192.39 Million | ▼ -2.0 pp |
| 2019 | 45.9% | $117.39 Million | $255.91 Million | $138.53 Million | ▲ +17.1 pp |
| 2018 | 28.8% | $70.64 Million | $245.45 Million | $174.81 Million | ▲ +17.5 pp |
| 2017 | 11.3% | $22.56 Million | $199.38 Million | $176.82 Million | ▼ -10.4 pp |
| 2016 | 21.7% | $28.89 Million | $133.34 Million | $104.45 Million | ▼ -19.7 pp |
| 2015 | 41.3% | $26.06 Million | $63.06 Million | $37.00 Million | ▼ -12.2 pp |
| 2014 | 53.6% | $36.29 Million | $67.75 Million | $31.46 Million | ▲ +37.6 pp |
| 2013 | 16.0% | $6.92 Million | $43.37 Million | $36.45 Million | ▲ +61.4 pp |
| 2012 | -45.4% | $-10.12 Million | $22.28 Million | $32.40 Million | ▼ -40.6 pp |
| 2011 | -4.8% | $-1.54 Million | $32.01 Million | $33.55 Million | ▼ -31.9 pp |
| 2010 | 27.1% | $13.43 Million | $49.59 Million | $36.16 Million | ▲ +3.3 pp |
| 2009 | 23.8% | $19.07 Million | $80.07 Million | $60.99 Million | ▲ +5.1 pp |
| 2008 | 18.7% | $17.45 Million | $93.40 Million | $75.96 Million | ▼ -11.7 pp |
| 2007 | 30.3% | $50.58 Million | $166.72 Million | $116.14 Million | ▼ -32.7 pp |
| 2006 | 63.0% | $65.78 Million | $104.37 Million | $38.59 Million | ▼ -20.1 pp |
| 2005 | 83.1% | $34.04 Million | $40.96 Million | $6.93 Million | — |